RMD 0.54% $37.28 resmed inc

Credit Suisse First quarter revenue was below Credit Suisse...

  1. 3,251 Posts.
    lightbulb Created with Sketch. 71
    Credit Suisse
    First quarter revenue was below Credit Suisse forecasts. US mask sales were flat and management notes some loss of share as well as distributors potentially holding back purchases ahead of the launch of new products.

    New mask products are needed to drive growth and the broker believes this, in turn, should lead to a recovery in gross margin.
    Target is reduced to $9.00 from $9.40 and Outperform retained.
    Sector: Health Care Equipment & Services.
    Target price is $9.00.Current Price is $8.08. Difference: $0.92 - (brackets indicate current price is over target). If RMD meets the Credit Suisse target it will return approximately 10% (excluding dividends, fees and charges - negative figures indicate an expected loss)
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.28
Change
0.200(0.54%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.50 $37.55 $37.15 $17.93M 480.5K

Buyers (Bids)

No. Vol. Price($)
1 3363 $37.27
 

Sellers (Offers)

Price($) Vol. No.
$37.30 1001 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.